Professional overview
Associate Chief Physician in the Department of Interventional Oncology at Renji Hospital (East Campus), specializing in image-guided minimally invasive interventions for solid tumors and benign conditions.
Department leadership
A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.
Areas of focus
Background
- 2014Recipient of the Trainee Research Prize at the Radiological Society of North America (RSNA) Annual Meeting
- 2024Recipient of the 2024 Interventional Rising Star Award at the Chinese College of Interventional Radiology Annual Meeting (CCI)
Experience & recognition
- First-author (including co-first-author) publications in Nature, Signal Transduction and Targeted Therapy (STTT), Radiology, Clinical Cancer Research, and Cancer Communication
- 15 first-author (including co-first-author) SCI publications and 5 core Chinese journal publications
- Principal investigator of 1 National Natural Science Foundation of China (NSFC) project, 1 Shanghai Natural Science Foundation project, and 1 Society of Interventional Radiology (SIR) project
- Principal investigator of 2 Renji Hospital Clinical Research Innovation Incubation Fund projects
- Contributor to multiple projects funded by the Ministry of Science and Technology (MOST), National Natural Science Foundation of China (NSFC), and Shanghai Municipal Science and Technology Commission
Professional roles
- Member, Interventional Oncology Professional Committee, China Anti-Cancer Association (CACA)
- Member, Minimally Invasive Treatment Professional Committee, China Anti-Cancer Association (CACA)
- Member, Youth Expert Working Group, Chinese Medical Doctor Association (CMDA) Interventional Physicians Branch
- Standing Committee Member, Minimally Invasive Treatment Professional Committee, Shanghai Anti-Cancer Association
- Member, Ablation Therapy Professional Committee, Shanghai Anti-Cancer Association
- Deputy Leader, Youth Committee, Interventional Oncology Specialty Branch, Shanghai Medical Association
- Member, Interventional Diagnosis and Treatment Expert Committee, Bethune Public Welfare Foundation
Frequently asked questions
What does Dr. Shi Yaoping specialize in?
Specializes in comprehensive interventional treatment of malignant solid tumors (e.g., liver cancer, lung cancer, kidney cancer) using ablation, transarterial chemoembolization, and radioactive seed implantation; diagnosis and ablation of pulmonary and thyroid nodules; embolization for benign conditions including hepatic hemangioma, splenomegaly, uterine fibroids, renal angiomyolipoma, and benign prostatic hyperplasia; PTCD and cyst sclerotherapy; embolization for hemoptysis, gastrointestinal bleeding, and renal hemorrhage; and ultrasound/CT-guided biopsy.
Which hospital and department is Dr. Shi Yaoping in?
Department of Interventional Oncology at Renji Hospital (East Campus)
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Shi Yaoping has not reviewed this page. Request a correction or removal.
